Related Experiment Video
Updated: Apr 10, 2026

11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.6K
The Merck "3 Baskets" approach for creating roadmaps to phase out animal testing
Kerstin Kleinschmidt-Doerr, Frederic C Pipp1, Isabelle Colmagne-Poulard2
1Corporate Animal Affairs, Merck KGaA, Darmstadt, Germany.
ALTEX
|November 28, 2025
Summary
Merck KGaA
Area of Science:
- Chemical safety assessment
- Pharmaceutical industry
- Animal testing alternatives
Background:
- Global roadmaps aim to phase out animal testing in chemical safety and pharmaceuticals.
- Regulatory bodies like the European Commission and US FDA are driving this transition.
- Industry initiatives are crucial for developing and implementing alternative methods.
Purpose of the Study:
- To present Merck KGaA's 4R program (Replace, Reduce, Refine, Responsibility) for reducing animal testing.
- To outline a strategic 3-basket approach for categorizing and managing animal tests.
- To achieve significant reductions in animal testing by 2032 and 2040.
Main Methods:
- Categorization of animal tests into three baskets: Adoption, Adaptation, and Assessment.
- Focus on achievable alternatives for immediate implementation.
- Strategic investment in research for future replacement strategies.
Main Results:
- A structured approach to reduce animal testing by 50% by 2032 and 75% by 2040.
- Identification of tests with available alternatives (Basket 1), in-development alternatives (Basket 2), and those needing new strategies (Basket 3).
- A collaborative agreement by EFPIA members to adopt the 3-basket approach.
Conclusions:
- The 3-basket strategy provides actionable milestones for replacing animal testing.
- This approach fosters ethical and sustainable scientific practices.
- Industry-wide collaboration, like the EFPIA agreement, is key to advancing animal testing alternatives.
Related Concept Videos
Clinical Trials
11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.2K
Drug Discovery: Overview
13.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.4K
Clinical Trials: Overview
5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
Preclinical Development: Overview
6.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
558
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
558
Drug Administration and Therapy Phases: Overview
2.0K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
2.0K

